Saudi Journal of Kidney Diseases and Transplantation

RENAL DATA FROM THE ARAB WORLD
Year
: 2010  |  Volume : 21  |  Issue : 3  |  Page : 548--554

Prevention of hepatitis C virus in hemodialysis patients: Five years experience from a single center


Waleed Z Mohamed 
 Nephrology Division, Medical Department, Dawmat Aljandal General Hospital, Aljouf, Saudi Arabia

Correspondence Address:
Waleed Z Mohamed
Nephrology Division, Medical Department, Dawmat Aljandal General Hospital, Dawmat Aljandal, Aljouf
Saudi Arabia

Hepatitis C virus (HCV) has been a significant problem in hemodialysis (HD) pa­tients. In general, it carries significant morbidity including liver cirrhosis, liver cell failure and hepa­toma. The study was conducted on 36 seronegative HD patients. All patients were managed with strict application of infection control guidelines as well as isolation of HCV-positive patients. None of the patients received any blood transfusions and were managed with iron and erythro­poietin. After five years of follow-up, we found that the incidence of HCV seroconversion was zero. Our study further suggests that following infection control guidelines, isolation of sero­positive patients and minimizing blood transfusions can help in prevention of HCV transmission among HD patients.


How to cite this article:
Mohamed WZ. Prevention of hepatitis C virus in hemodialysis patients: Five years experience from a single center.Saudi J Kidney Dis Transpl 2010;21:548-554


How to cite this URL:
Mohamed WZ. Prevention of hepatitis C virus in hemodialysis patients: Five years experience from a single center. Saudi J Kidney Dis Transpl [serial online] 2010 [cited 2019 Aug 19 ];21:548-554
Available from: http://www.sjkdt.org/article.asp?issn=1319-2442;year=2010;volume=21;issue=3;spage=548;epage=554;aulast=Mohamed;type=0